Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Cost of Revenue (2016 - 2025)

Chemours (CC) has 12 years of Cost of Revenue data on record, last reported at $1.2 billion in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 8.1% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $4.9 billion, up 5.89%, while the annual FY2025 figure was $1.2 billion, 74.7% down from the prior year.
  • Cost of Revenue reached $1.2 billion in Q4 2025 per CC's latest filing, down from $1.3 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.4 billion in Q2 2022 and bottomed at $1.1 billion in Q1 2024.
  • Average Cost of Revenue over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2023.
  • Peak YoY movement for Cost of Revenue: skyrocketed 55.59% in 2021, then fell 11.85% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $1.2 billion in 2021, then fell by 0.76% to $1.2 billion in 2022, then decreased by 4.77% to $1.1 billion in 2023, then decreased by 2.78% to $1.1 billion in 2024, then grew by 8.1% to $1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $1.2 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.